SCHEMBL15958293

SCHEMBL15958293

Cc1cc2nc(OC(C)(C)C)c(-c3cccs3)nc2cc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 7/20 0.51
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
ALDH1A1 P00352 5/20 0.41
NPSR1 Q6W5P4 2/20 0.41
SRPK1 Q96SB4 1/20 0.39
HTT P42858 2/20 0.39
SMPD3 Q9NY59 1/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 1/20 0.38
PGK1 P00558 1/20 0.38
KDM4E B2RXH2 3/20 0.38
GAA P10253 2/20 0.38
GFER P55789 1/20 0.38
LMNA P02545 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15958294 0.88 RPS6KB2 (0.48) RPS6KB2NPC1RAB9AALDH1A1SRPK1
SCHEMBL12669815 0.87 RPS6KB2 (0.49) RPS6KB2NPC1RAB9AALDH1A1NPSR1
SCHEMBL12669818 0.86 RPS6KB2 (0.72) RPS6KB2NPC1RAB9AALDH1A1NPSR1
SCHEMBL12669817 0.83 RPS6KB2 (0.52) RPS6KB2NPC1RAB9AALDH1A1HTT
SCHEMBL12669924 0.83 RPS6KB2 (0.52) RPS6KB2NPC1RAB9AALDH1A1HTT
SCHEMBL12669819 0.83 RPS6KB2 (0.69) RPS6KB2RAB9AALDH1A1NPSR1SRPK1
SCHEMBL6236081 0.82 RPS6KB2 (0.70) RPS6KB2NPC1RAB9AALDH1A1SRPK1
SCHEMBL15958680 0.81 RAB9A (0.52) RPS6KB2NPC1RAB9AALDH1A1NPSR1
SCHEMBL7917553 0.81 ADORA2A (0.44) RPS6KB2NPC1RAB9AALDH1A1NPSR1
SCHEMBL7907933 0.76 ALDH1A1 (0.39) RPS6KB2NPC1RAB9AALDH1A1SMPD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809264-B2 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2014-08-19 US disclosed